Kantonsspital St.Gallen

SAKK 01/18 Reduced intensity radio-chemotherapy for satge IIA/B seminoma. A multicenter, open label phase II trial with 2 cohorts

Paul Martin Putora, Ludwig Plasswilm, Aurelius Omlin, Christian Rothermundt & Stefanie Aeppli

abstract Main objective: To investigate efficacy of a stage-adapted tratment regimen in stage IIA/B seminoma based on the preliminary experience gained in SAKK 01/10. The Goal is to further safely de-escalate Treatment while maintaining / enhancing efficacy.
type of project clinical studies
status ongoing - recruiting phase
start of project 2019
end of project 2030
study design multicenter, open Label Phase II with two cohorts
responsible person PD Dr. paul Martin Putora